Literature DB >> 26476380

Fungal Sinusitis.

Eytan Raz1, William Win1, Mari Hagiwara1, Yvonne W Lui1, Benjamin Cohen1, Girish M Fatterpekar2.   

Abstract

Fungal sinusitis is characterized into invasive and noninvasive forms. The invasive variety is further classified into acute, chronic and granulomatous forms; and the noninvasive variety into fungus ball and allergic fungal sinusitis. Each of these different forms has a unique radiologic appearance. The clinicopathologic and corresponding radiologic spectrum and differences in treatment strategies of fungal sinusitis make it an important diagnosis for clinicians and radiologists to always consider. This is particularly true of invasive fungal sinusitis, which typically affects immuno compromised patients and is associated with significant morbidity and mortality. Early diagnosis allows initiation of appropriate treatment strategies resulting in favorable outcome. Published by Elsevier Inc.

Entities:  

Keywords:  Allergic fungal sinusitis; Granulomatous fungal sinusitis; Invasive fungal sinusitis; Noninvasive fungal sinusitis

Mesh:

Year:  2015        PMID: 26476380     DOI: 10.1016/j.nic.2015.07.004

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  3 in total

1.  Clinical pattern of fungal balls in the paranasal sinuses: our experience with 70 patients.

Authors:  Min Young Seo; Seung Hoon Lee; Gwanghui Ryu; Sang Duk Hong; Hyo Yeol Kim; Hun-Jong Dhong; Seung-Kyu Chung
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-03       Impact factor: 2.503

Review 2.  Fungal Rhinosinusitis: Unravelling the Disease Spectrum.

Authors:  Virendra Singh
Journal:  J Maxillofac Oral Surg       Date:  2019-01-28

Review 3.  Imaging features of benign mass lesions in the nasal cavity and paranasal sinuses according to the 2017 WHO classification.

Authors:  Hiroyuki Tatekawa; Taro Shimono; Masahiko Ohsawa; Satoshi Doishita; Shinichi Sakamoto; Yukio Miki
Journal:  Jpn J Radiol       Date:  2018-04-25       Impact factor: 2.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.